Lanean...
The use of nebulized pharmacotherapies during the COVID-19 pandemic
Coronavirus disease 2019 (COVID-19), caused by the highly contagious novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a worldwide pandemic and currently represents a major public health issue. COVID-19 has highlighted the need for clear and accurate guidance on the...
Gorde:
| Argitaratua izan da: | Ther Adv Respir Dis |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675890/ https://ncbi.nlm.nih.gov/pubmed/33167796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466620954366 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|